Table 1.

HIV-RNA and total HIV-DNA loads in plasma and semen in patients with detectable HIV-RNA or HIV-DNA in semen at W48

Subject IDRegimen typeSemen HIV-1- RNA (log10 copies/mL)
Semen total HIV-1-DNA (log10 copies/106 cells)
Plasma HIV-1- RNA (log10 copies/mL)
Blood total HIV-1-DNA (log10 copies/106 PBMCs)
Observations
W0W48W0W48W0W48W0W48
#1DTG(W2) 2.751.79(W2) 2.84<3.204.16<0.523.222.76self-reported correct treatment adherence until W24; no response for W48
#2DTG6.482.94NANA6.391.693.722.83self-reported adherence failures at W4 and W48
#3DRVNA2.40NA1.886.45detected <0.524.212.74self-reported adherence failures at W4 and W24
#4DRV6.041.571.59<1.505.741.003.962.80self-reported adherence failures at W8 and W24
#5DRVNA3.28NA<2.116.892.204.263.56self-reported correct treatment adherence until W12; no responses for W24 and W48; STI W24, W36 and W48
#6DRVNA1.50NA<1.995.851.754.053.15self-reported adherence failures at W8, W24, W36 and W48; STI W24
#7DRV(W2) <1.71<2.13(W2) <1.712.364.940.483.182.39self-reported adherence failures at W4, W8, W36 and W48; STI W36
#8DTGNA<2.01NA2.575.311.183.762.76self-reported adherence failures at each timepoint
Subject IDRegimen typeSemen HIV-1- RNA (log10 copies/mL)
Semen total HIV-1-DNA (log10 copies/106 cells)
Plasma HIV-1- RNA (log10 copies/mL)
Blood total HIV-1-DNA (log10 copies/106 PBMCs)
Observations
W0W48W0W48W0W48W0W48
#1DTG(W2) 2.751.79(W2) 2.84<3.204.16<0.523.222.76self-reported correct treatment adherence until W24; no response for W48
#2DTG6.482.94NANA6.391.693.722.83self-reported adherence failures at W4 and W48
#3DRVNA2.40NA1.886.45detected <0.524.212.74self-reported adherence failures at W4 and W24
#4DRV6.041.571.59<1.505.741.003.962.80self-reported adherence failures at W8 and W24
#5DRVNA3.28NA<2.116.892.204.263.56self-reported correct treatment adherence until W12; no responses for W24 and W48; STI W24, W36 and W48
#6DRVNA1.50NA<1.995.851.754.053.15self-reported adherence failures at W8, W24, W36 and W48; STI W24
#7DRV(W2) <1.71<2.13(W2) <1.712.364.940.483.182.39self-reported adherence failures at W4, W8, W36 and W48; STI W36
#8DTGNA<2.01NA2.575.311.183.762.76self-reported adherence failures at each timepoint

NA, not available; DTG, dolutegravir-based regimen; DRV, darunavir-based regimen; STI, sexually transmitted infection.

Table 1.

HIV-RNA and total HIV-DNA loads in plasma and semen in patients with detectable HIV-RNA or HIV-DNA in semen at W48

Subject IDRegimen typeSemen HIV-1- RNA (log10 copies/mL)
Semen total HIV-1-DNA (log10 copies/106 cells)
Plasma HIV-1- RNA (log10 copies/mL)
Blood total HIV-1-DNA (log10 copies/106 PBMCs)
Observations
W0W48W0W48W0W48W0W48
#1DTG(W2) 2.751.79(W2) 2.84<3.204.16<0.523.222.76self-reported correct treatment adherence until W24; no response for W48
#2DTG6.482.94NANA6.391.693.722.83self-reported adherence failures at W4 and W48
#3DRVNA2.40NA1.886.45detected <0.524.212.74self-reported adherence failures at W4 and W24
#4DRV6.041.571.59<1.505.741.003.962.80self-reported adherence failures at W8 and W24
#5DRVNA3.28NA<2.116.892.204.263.56self-reported correct treatment adherence until W12; no responses for W24 and W48; STI W24, W36 and W48
#6DRVNA1.50NA<1.995.851.754.053.15self-reported adherence failures at W8, W24, W36 and W48; STI W24
#7DRV(W2) <1.71<2.13(W2) <1.712.364.940.483.182.39self-reported adherence failures at W4, W8, W36 and W48; STI W36
#8DTGNA<2.01NA2.575.311.183.762.76self-reported adherence failures at each timepoint
Subject IDRegimen typeSemen HIV-1- RNA (log10 copies/mL)
Semen total HIV-1-DNA (log10 copies/106 cells)
Plasma HIV-1- RNA (log10 copies/mL)
Blood total HIV-1-DNA (log10 copies/106 PBMCs)
Observations
W0W48W0W48W0W48W0W48
#1DTG(W2) 2.751.79(W2) 2.84<3.204.16<0.523.222.76self-reported correct treatment adherence until W24; no response for W48
#2DTG6.482.94NANA6.391.693.722.83self-reported adherence failures at W4 and W48
#3DRVNA2.40NA1.886.45detected <0.524.212.74self-reported adherence failures at W4 and W24
#4DRV6.041.571.59<1.505.741.003.962.80self-reported adherence failures at W8 and W24
#5DRVNA3.28NA<2.116.892.204.263.56self-reported correct treatment adherence until W12; no responses for W24 and W48; STI W24, W36 and W48
#6DRVNA1.50NA<1.995.851.754.053.15self-reported adherence failures at W8, W24, W36 and W48; STI W24
#7DRV(W2) <1.71<2.13(W2) <1.712.364.940.483.182.39self-reported adherence failures at W4, W8, W36 and W48; STI W36
#8DTGNA<2.01NA2.575.311.183.762.76self-reported adherence failures at each timepoint

NA, not available; DTG, dolutegravir-based regimen; DRV, darunavir-based regimen; STI, sexually transmitted infection.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close